EMNEastman Chemical Company

$62.72-0.12% 1Y

EMN as reported

Eastman Chemical Company reported $8.87B of revenue over the trailing twelve months, −4.5% on the year before. 11 reported series are charted on this page, each one as filed.

$8.87B

Revenue, trailing twelve months · to Q2 2026 · −4.5% against the twelve months before

Net income
$442M

Net income · −47% year on year · trailing twelve months to Q2 2026

Free cash flow
$539M

Free cash flow · +33% year on year · trailing twelve months to Q2 2026

EPS
$3.84

EPS · −46% year on year · trailing twelve months to Q2 2026

Details›
Every series Ryufin has for EMN, trailing twelve months
SeriesLatestYear on yearAs of
Revenue$8.87B−4.5%Q2 2026
Net income$442M−47%Q2 2026
EPS$3.84−46%Q2 2026
Gross margin20%n/aQ2 2026
Operating margin16%n/aQ4 2017 · 34 quarters behind
Net margin4.9%n/aQ2 2026
ROE8.5%n/aQ2 2026
ROA3.3%n/aQ2 2026
ROIC10%n/aQ4 2017 · 34 quarters behind
Free cash flow$539M+33%Q2 2026
P/E16.3n/atoday

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

Revenue and profitEastman Chemical Company (EMN)
RevenueNet incomeTrailing twelve months
Powered byryufin.com